We are live on ! Find out more
RE

RBC Europe Portfolio holdings

AUM $2.08B
1-Year Est. Return 12.2%
This Fund
S&P 500
This Quarter Est. Return
+5.62%
1 Year Est. Return
-12.2%
3 Year Est. Return
+59.81%
5 Year Est. Return
+127.03%
10 Year Est. Return
–
AUM
$852M
AUM Growth
+$34.2M
Cap. Flow
-$2.21M
Cap. Flow %
-0.26%
Top 10 Hldgs %
41.05%
Holding
1,206
New
80
Increased
123
Reduced
188
Closed
61

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$4.02M
2
MSFT icon
Microsoft
MSFT
+$2.15M
3
META icon
Meta Platforms (Facebook)
META
+$1.41M
4
V icon
Visa
V
+$1.37M
5
MKC icon
McCormick & Company Non-Voting
MKC
+$905K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$4.54M
2
KDP icon
Keurig Dr Pepper
KDP
+$3.78M
3
MON
Monsanto Co
MON
+$1.55M
4
VZ icon
Verizon
VZ
+$1.04M
5
PM icon
Philip Morris
PM
+$809K

Sector Composition

Rank Sector Weight
1 Financials 22.14%
2 Consumer Discretionary 16.55%
3 Technology 16.32%
4 Communication Services 12.04%
5 Healthcare 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENFY
1101
DELISTED
Enlightify Inc
ENFY
$575 ﹤0.01%
42
-166
-80% -$2.46K
AVEO
1102
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$574 ﹤0.01%
25
– –
CGRN
1103
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$572 ﹤0.01%
40
– –
MNKD icon
1104
MannKind Corp
MNKD
$1.27B
$532 ﹤0.01%
280
– –
XONE
1105
DELISTED
The ExOne Company
XONE
$496 ﹤0.01%
70
– –
HK
1106
DELISTED
Halcon Resources Corporation
HK
$487 ﹤0.01%
111
– –
INSY
1107
DELISTED
Insys Therapeutics, Inc.
INSY
$471 ﹤0.01%
65
– –
MERC icon
1108
Mercer International
MERC
$25.9M
$455 ﹤0.01%
26
– –
GROW icon
1109
US Global Investors
GROW
$41.3M
$435 ﹤0.01%
270
– –
RYAM icon
1110
Rayonier Advanced Materials
RYAM
$582M
$410 ﹤0.01%
24
– –
AVP
1111
DELISTED
Avon Products, Inc.
AVP
$405 ﹤0.01%
250
– –
DSKE
1112
DELISTED
Daseke, Inc. Common Stock
DSKE
$258 ﹤0.01%
+26
New +$242
ELOX
1113
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
– –
0
– –
GALT icon
1114
Galectin Therapeutics
GALT
$405M
$254 ﹤0.01%
40
– –
CRC
1115
DELISTED
California Resources Corporation
CRC
$227 ﹤0.01%
5
-53
-91% -$1.68K
APVO icon
1116
Aptevo Therapeutics
APVO
$4.27M
– –
0
– –
SCPX
1117
DELISTED
Scorpius Holdings, Inc.
SCPX
– –
0
– –
REGI
1118
DELISTED
Renewable Energy Group, Inc.
REGI
$214 ﹤0.01%
12
– –
BLRX
1119
BioLineRX
BLRX
$11.4M
– –
0
– –
OPTT icon
1120
Ocean Power Technologies
OPTT
$46.2M
$126 ﹤0.01%
7
– –
FAZ
1121
Direxion Daily Financial Bear 3x ETF
FAZ
$88.2M
– –
0
– –
GTE icon
1122
Gran Tierra Energy
GTE
$349M
$104 ﹤0.01%
3
– –
KZIA
1123
Kazia Therapeutics
KZIA
$155M
$95 ﹤0.01%
1
– –
TPST icon
1124
Tempest Therapeutics
TPST
$17.5M
– –
0
– –
ADXS
1125
DELISTED
Advaxis Inc
ADXS
$87 ﹤0.01%
4
– –
43 44
45
46 47

Similar funds

AP
Advisor Partners Walnut Creek, California $1.42B AUM 3.97% 1-Year Est. Return
AWM
Altium Wealth Management Purchase, New York $1.39B AUM 12.44% 1-Year Est. Return
FWM
Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return
BRWM
B. Riley Wealth Management Memphis, Tennessee $962M AUM 8.45% 1-Year Est. Return
BDWM
Brewin Dolphin Wealth Management Conskleagh, Dublin, Ireland $917M AUM 12.3% 1-Year Est. Return
DHFB
Dixon Hubard Feinour & Brown Roanoke, Virginia $842M AUM 2.74% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
TFM
TPI Fund Managers London, United Kingdom $597M AUM 7.13% 1-Year Est. Return

RBC Europe's Q2 2018 Portfolio in Review

As of Q2 2018, RBC Europe held 1,206 positions worth $852M, up 4.2% from $817M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

RBC Europe's Q2 2018 filing shows 80 new, 123 increased, 188 reduced and 61 closed positions. Its largest new stake was Pluralsight, Inc. Class A Common Stock: 12,370 shares worth $302K. The largest sale was Celgene Corp, an estimated $4.54M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Technology.

  • RBC Europe's largest Q2 2018 buy was Pluralsight, Inc. Class A Common Stock: 12,370 shares worth $302K.
  • RBC Europe added most to Berkshire Hathaway Class B in Q2 2018, an estimated $4.02M increase.
  • RBC Europe's biggest Q2 2018 reduction was Celgene Corp, cutting an estimated $4.54M.
  • RBC Europe fully exited Monsanto Co in Q2 2018, selling an estimated $1.55M.
  • RBC Europe's ten largest holdings make up 41% of its $852M portfolio in Q2 2018.
  • RBC Europe opened 80 new positions and closed 61 in Q2 2018.
  • RBC Europe's portfolio value rose 4.2% quarter-over-quarter to $852M.

Based on RBC Europe's 13F filing for Q2 2018, filed 9 Nov 2023.